Home > Healthcare & Medical Devices > Automated Breast Ultrasound Systems (ABUS) Market

Automated Breast Ultrasound Systems (ABUS) Market Size By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By End-use (Hospitals, Diagnostic Imaging Centers, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI728
  • Published Date: Oct 2022
  • Report Format: PDF

Industry Overview

Automated Breast Ultrasound Systems Market size was worth over USD 1.5 billion in 2021 and is anticipated to expand at more than 14% CAGR from 2022 to 2030.
 

A surge in cases of breast cancer worldwide will accelerate the use of automated breast ultrasound systems. High prevalence of obesity, age-related risks, reduced childbearing, and hormone replacement therapy is some of the prime factors contributing to a rise in breast cancer cases. In addition to this, excessive alcohol consumption, smoking, and living a sedentary lifestyle can further increase the risk of cancer.
 

Get more details on this report - Request Free Sample PDF
 

Growing concerns associated with breast cancer have led to the introduction of national breast screening programs across the globe. Government initiatives and population-based screening projects such as ASSURE, which is funded by the European Commission to detect early signs of breast cancer in women, will propel the use of ABUS.
 

High costs associated with automated breast ultrasound systems may impede market progress. Estimates suggest that cost of therapeutics is relatively high for advanced diseases. The lack of accessibility and affordability of novel treatments is also a major roadblock for many patients. Furthermore, the cost-intensive nature of the screening procedures makes product acquisition in low and middle-income countries very challenging, thus hindering ABUS market development.
 

High preference for minimally invasive diagnosis boosts demand for automated breast volume scanner

Get more details on this report - Request Free Sample PDF
 

Automated breast ultrasound systems market share from the automated breast volume scanner (ABVS) product segment is anticipated to exhibit over 14% CAGR between 2022-2030. ABVS uses high-frequency ultrasound light to assess the volumetric images of the breast and accurately examine lactiferous ducts with the help of a scanner. This ultrasound system offers several benefits including 3D reconstruction, non-radioactivity, time efficiency, repeatability, and sensitivity to dense breast tissues.
 

Growing patient inclination towards minimally invasive diagnostic procedures will fuel demand for ABVS. The system can be guided via real-time imaging support. Some of the other advantages associated with ABVS include quick & painless procedures and enhanced diagnostic precision that enables early diagnosis of breast cancer. The results derived from this technology can be used in insightful preoperative surgical planning.
 

Awareness of routine breast cancer screening tests to drive the use of ABUS in hospitals

Get more details on this report - Request Free Sample PDF
 

Automated breast ultrasound systems market from hospitals segment held a 45% share of the global industry  in 2021. The deployment of ABUS is steadily gaining momentum across more hospitals to address the diagnostics needs of patients. Increasing awareness among young and middle-aged women to regularly undergo cancer screening tests will propel the demand for ABUS and ABVS across these healthcare settings. As pregnant women cannot be exposed to a mammogram due to the risk of being emitted to radiation, hospitals are installing ABUS to offer safer diagnostic options.
 

Growing medical tourism to foster APAC market statistics

Get more details on this report - Request Free Sample PDF
 

Asia Pacific automated breast ultrasound systems market size is poised to exceed USD 2 billion by 2030. The region is experiencing an influx of public and private funding for spreading awareness regarding the early detection and treatment of breast cancer. The increasing expansion of healthcare infrastructure has made APAC a prominent hotspot for medical tourism. Nearly 2 million people from across Middle East & Africa, and neighboring countries such as Nepal and Bangladesh visit India each year for medical purposes.
 

New product launches to strengthen automated breast ultrasound systems industry development

Some of the leading companies in the automated breast ultrasound systems market include Delphinus Medical Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Metritrack, Inc, QView Medical Inc., Real Imaging, Siemens AG, SonoCine, Inc., Supersonic Imagine, Theraclion, CANON MEDICAL SYSTEMS CORPORATION, Volpara Solutions Limited, CapeRay Medical, Hitachi Ltd., Seno Medical Instruments Inc., and Shantou Institute of Ultrasonic Instruments Co., Ltd (SIUI). These companies are focusing on collaborations and agreements to boost innovation and introduce advanced products into the market.
 

Impact of COVID-19 pandemic on automated breast ultrasound systems market trends

The COVID-19 pandemic resulted in a slight decline in ABUS industry revenue share due to strict lockdowns implemented to curb transmission. The outbreak dramatically spiked hospitalization rates worldwide. Governments across the globe struggled with maintaining healthcare infrastructure due to a lack of expenditure and unavailability of equipment. Medical equipment manufacturers were also challenged with production issues due to the cessation of trade with China, which is one of the biggest raw material providers.
 

The automated breast ultrasound systems market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Product

  • Automated Breast Ultrasound System (ABUS)
  • Automated Breast Volume Scanner (ABVS)
  • Others

By End-use

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Centers

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Others

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market size for automated breast ultrasound systems reached over USD 1.5 billion and is projected to record more than 14% CAGR between 2022 to 2030.
Hospitals accounted for more than 45% business share in 2021, due to the high prevalence of routine breast cancer screening tests.
Asia Pacific automated breast ultrasound systems market size is estimated to go beyond USD 2 billion by 2030 owing to increasing medical tourism in countries like India.
GE Healthcare, Metritrack, Inc, Real Imaging, Siemens AG, SonoCine, Inc., Supersonic Imagine, CapeRay Medical, and Hitachi Ltd. are some of the leading companies in the global ABUS market.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 16
  • Tables & Figures: 138
  • Countries covered: 18
  • Pages: 160
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount